Witty says pharma price decline speeds up

Wednesday 27 June 2012

The erosion of pharmaceutical prices in Europe has accelerated with the debt crisis and prices now look set to decline by 5% or more, according to Andrew Witty, president of the European pharmaceutical industry federation, EFPIA, and chief executive of GlaxoSmithKline Plc.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Belgium